Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

639 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues.
Kyo S, Kanaya T, Takakura M, Tanaka M, Inoue M. Kyo S, et al. Int J Cancer. 1999 Jan 5;80(1):60-3. doi: 10.1002/(sici)1097-0215(19990105)80:1<60::aid-ijc12>;2-e. Int J Cancer. 1999. PMID: 9935231
Loss of autophagy-related protein Beclin 1 may define poor prognosis in ovarian clear cell carcinomas.
Katagiri H, Nakayama K, Razia S, Nakamura K, Sato E, Ishibashi T, Ishikawa M, Iida K, Ishikawa N, Otsuki Y, Nakayama S, Kyo S. Katagiri H, et al. Int J Oncol. 2015 Dec;47(6):2037-44. doi: 10.3892/ijo.2015.3191. Epub 2015 Oct 6. Int J Oncol. 2015. PMID: 26458502 Free PMC article.
CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas.
Nakayama K, Rahman MT, Rahman M, Nakamura K, Ishikawa M, Katagiri H, Sato E, Ishibashi T, Iida K, Ishikawa N, Kyo S. Nakayama K, et al. Int J Oncol. 2016 Feb;48(2):506-16. doi: 10.3892/ijo.2015.3268. Epub 2015 Nov 26. Int J Oncol. 2016. PMID: 26647729 Free PMC article.
ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma.
Sato E, Nakayama K, Razia S, Nakamura K, Ishikawa M, Minamoto T, Ishibashi T, Yamashita H, Iida K, Kyo S. Sato E, et al. Int J Mol Sci. 2018 Jun 8;19(6):1710. doi: 10.3390/ijms19061710. Int J Mol Sci. 2018. PMID: 29890703 Free PMC article.
KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions.
Nakamura K, Nakayama K, Ishibashi T, Ishikawa N, Ishikawa M, Katagiri H, Minamoto T, Sato E, Sanuki K, Yamashita H, Iida K, Sultana R, Kyo S. Nakamura K, et al. Int J Mol Sci. 2016 Apr 26;17(5):625. doi: 10.3390/ijms17050625. Int J Mol Sci. 2016. PMID: 27128903 Free PMC article.
Molecular characterization of CD133+ cancer stem-like cells in endometrial cancer.
Nakamura M, Zhang X, Mizumoto Y, Maida Y, Bono Y, Takakura M, Kyo S. Nakamura M, et al. Int J Oncol. 2014 Mar;44(3):669-77. doi: 10.3892/ijo.2013.2230. Epub 2013 Dec 23. Int J Oncol. 2014. PMID: 24366104
Dienogest, a synthetic progestin, inhibits prostaglandin E2 production and aromatase expression by human endometrial epithelial cells in a spheroid culture system.
Shimizu Y, Mita S, Takeuchi T, Notsu T, Mizuguchi K, Kyo S. Shimizu Y, et al. Steroids. 2011 Jan;76(1-2):60-7. doi: 10.1016/j.steroids.2010.08.010. Epub 2010 Sep 21. Steroids. 2011. PMID: 20851710
Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth.
Kyo S, Sakaguchi J, Kiyono T, Shimizu Y, Maida Y, Mizumoto Y, Mori N, Nakamura M, Takakura M, Miyake K, Sakamoto M, Inoue M. Kyo S, et al. Clin Cancer Res. 2011 Feb 1;17(3):525-37. doi: 10.1158/1078-0432.CCR-10-1287. Epub 2010 Dec 3. Clin Cancer Res. 2011. PMID: 21131554
Platelet-derived microparticles and soluble factors differentially regulate human endometrial epithelial cell movement.
Suginami K, Sato Y, Horie A, Matsumoto H, Tani H, Mizumoto Y, Ono M, Matsuoka A, Kyo S, Araki Y, Konishi I, Fujiwara H. Suginami K, et al. Am J Reprod Immunol. 2017 Apr;77(4). doi: 10.1111/aji.12641. Epub 2017 Feb 7. Am J Reprod Immunol. 2017. PMID: 28168784
639 results
Jump to page